SEC 13F Intelligence

Managers / Q4 2025 · view latest →

Madryn Asset Management, LP

CIK 0001787423 · 330 MADISON AVENUE, 33RD FLOOR, NEW YORK, NY, 10017 · 6465605493

Reported Value
$35M
Q4 2025
Positions
3
Filings on Record
12
2019–present window
Filed
Feb 10, 2026
original filing

Summary

Madryn Asset Management, LP reported $35M in U.S.-listed holdings across 3 positions for Q4 2025.

The portfolio is heavily concentrated: STIM alone accounts for 73.4% of reported value.

Compared with Q3 2023, the fund opened 3 new positions and exited 5.

Portfolio Metrics

Turnover
+98.1%
vs prior filed quarter
Largest Position
+73.4%
Neuronetics
New / Exited
3 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’22: $115MQ1 ’22Q2 ’22: $76MQ2 ’22Q3 ’22: $63MQ3 ’22Q1 ’23: $76MQ1 ’23Q2 ’23: $44MQ2 ’23Q3 ’23: $36MQ3 ’23Q4 ’25: $35MQ4 ’25Q1 ’26: $34MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $35M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline) · note: prior filed quarter, not the immediately preceding one

IssuerMoveShare ΔShares nowValue ΔValue now
STIMNEURONETICS INCNEW+18.48M18.48M+$25M$25M
OMDAOMADA HEALTH INCNEW+583.8K583.8K+$9M$9M
VEROVENUS CONCEPT INCNEW+10.2K10.2K+$15,075$15,075
SOMALOGIC INCSOLD OUT7.47M0$18M$0
ESTAESTABLISHMENT LABS HLDGS INCSOLD OUT321.1K0$16M$0
GREENBROOK TMSSOLD OUT6.36M0$2M$0
SOMALOGIC INCSOLD OUT838.1K0$595,962$0
VENUS CONCEPT INCSOLD OUT112.0K0$219,598$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2025

3 positions
#IssuerClass% PortfolioValueShares
1STIMNEURONETICS INChistory →COM73.43%$25M18.48M
2OMDAOMADA HEALTH INChistory →COM26.53%$9M583.8K
3VEROVENUS CONCEPT INCCOM0.04%$15,07510.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$34M2May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$35M3Feb 10, 202613F-HRchanges · EDGAR ↗
Q3 2023$36M5Nov 2, 202313F-HRchanges · EDGAR ↗
Q2 2023$44M5Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$76M5May 12, 2023RESTATEMENTchanges · EDGAR ↗
Q3 2022$63M4Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$76M4Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$115M4May 27, 2022RESTATEMENTchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.